{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:40:59Z","timestamp":1784547659288,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coi.2025.102714","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:06:39Z","timestamp":1767920799000},"page":"102714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of stromal cell immunobiology in understanding and managing Sj\u00f6gren\u2019s disease"],"prefix":"10.1016","volume":"99","author":[{"given":"Valeria","family":"Manfr\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Quartuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102714_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sjogren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2025.102714_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sjogren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102714_bib3","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","article-title":"Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) Mesenchymal Stromal Cell committee position statement on nomenclature","volume":"21","author":"Viswanathan","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.coi.2025.102714_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/14712598.2015.997204","article-title":"Homing properties of mesenchymal stromal cells","volume":"15","author":"Kallmeyer","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.coi.2025.102714_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.isci.2019.05.004","article-title":"Mesenchymal stromal cell homing: mechanisms and strategies for improvement","volume":"15","author":"Ullah","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.coi.2025.102714_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01855-9","article-title":"Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress","volume":"11","author":"Wu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.coi.2025.102714_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coi.2025.102714_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1359\/jbmr.1997.12.9.1335","article-title":"Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo","volume":"12","author":"Kuznetsov","year":"1997","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.coi.2025.102714_bib10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.exphem.2007.12.015","article-title":"Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts","volume":"36","author":"Covas","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.coi.2025.102714_bib11","first-page":"131","article-title":"Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Koski","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2025.102714_bib12","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102714_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03344-6","article-title":"Immunofibroblasts regulate LT\u03b13 expression in tertiary lymphoid structures in a pathway dependent on ICOS\/ICOSL interaction","volume":"5","author":"Nayar","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.coi.2025.102714_sbref14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54686-0","article-title":"Molecular and spatial analysis of tertiary lymphoid structures in Sjogren\u2019s syndrome","volume":"16","author":"Nayar","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102714_bib15","first-page":"481","article-title":"Cross-tissue, single-cell stromal atlas identifies shared pathological fibroblast phenotypes in four chronic inflammatory diseases","volume":"3","author":"Korsunsky","year":"2022","journal-title":"Med N"},{"key":"10.1016\/j.coi.2025.102714_sbref16","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107943","article-title":"Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sj\u00f6gren\u2019s syndrome","volume":"26","author":"Xiang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.coi.2025.102714_sbref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100248","article-title":"Single-cell transcriptomic analysis uncovers heterogeneity in the labial gland microenvironment of primary Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Huang","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.coi.2025.102714_bib18","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1093\/rheumatology\/keac111","article-title":"Ruxolitinib inhibits IFN\u03b3-stimulated Sj\u00f6gren\u2019s salivary gland MSC HLA-DR expression and chemokine-dependent T-cell migration","volume":"61","author":"McCoy","year":"2022","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.coi.2025.102714_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells14080558","article-title":"Pro-inflammatory properties of salivary gland-derived fibroblasts\u2014implications in Sj\u00f6gren\u2019s disease","volume":"14","author":"Brunner","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.coi.2025.102714_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcyt.2020.09.008","article-title":"Minor salivary gland mesenchymal stromal cells derived from patients with Sj\u04e7gren\u2019s syndrome deploy intact immune plasticity","volume":"23","author":"McCoy","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.coi.2025.102714_bib21","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102714_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749192","article-title":"Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/394917","article-title":"Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications","volume":"2015","author":"Castro-Manrreza","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.coi.2025.102714_bib24","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jcyt.2014.07.004","article-title":"Tryptophan concentration is the main mediator of the capacity of adipose mesenchymal stromal cells to inhibit T-lymphocyte proliferation in vitro","volume":"16","author":"Menta R","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.coi.2025.102714_bib25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/scd.2018.0033","article-title":"Immunosuppression of human adipose-derived stem cells on T cell subsets via the reduction of NF-kappaB activation mediated by PD-L1\/PD-1 and Gal-9\/TIM-3 pathways","volume":"27","author":"Zhou","year":"2018","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.coi.2025.102714_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1165\/rcmb.2017-0326OC","article-title":"PD-1\/PD-L1 pathway mediates the alleviation of pulmonary fibrosis by human mesenchymal stem cells in humanized mice","volume":"58","author":"Ni","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coi.2025.102714_bib27","article-title":"Mesenchymal stromal cells rapidly suppress TCR signaling-mediated cytokine transcription in activated T cells through the ICAM-1\/CD43 interaction","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib28","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.0902023","article-title":"Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression","volume":"184","author":"Ren","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jcmm.12247","article-title":"New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. lessons from the heart","volume":"18","author":"Bani","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.coi.2025.102714_bib30","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.celrep.2019.02.101","article-title":"Colonic CD90+ crypt fibroblasts secrete semaphorins to support epithelial growth","volume":"26","author":"Karpus","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2025.102714_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038615","article-title":"Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sj\u00f6gren\u2019s-like disease","volume":"7","author":"Khalili","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2025.102714_bib32","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-1855","article-title":"Umbilical cord mesenchymal stem cells alleviate Sj\u00f6gren\u2019s syndrome and related pulmonary inflammation through regulating V\u03b34+ IL-17+ T cells","volume":"10","author":"Cong","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.coi.2025.102714_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-018-1023-x","article-title":"Mesenchymal stem cell transplantation ameliorates Sj\u00f6gren\u2019s syndrome via suppressing IL-12 production by dendritic cells","volume":"9","author":"Shi","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.coi.2025.102714_bib34","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.7150\/thno.37351","article-title":"Mesenchymal stem cell transplantation alleviates experimental Sj\u00f6gren\u2019s syndrome through IFN-\u03b2\/IL-27 signaling axis","volume":"9","author":"Yao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.coi.2025.102714_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/JLB.6MA0921-752RR","article-title":"Stem cells from exfoliated deciduous teeth transplantation ameliorates Sj\u00f6gren\u2019s syndrome by secreting soluble PD-L1","volume":"111","author":"Yang","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coi.2025.102714_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/14397595.2019.1707996","article-title":"Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sj\u00f6gren\u2019s syndrome by inducing regulatory T cells","volume":"31","author":"Liu","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.coi.2025.102714_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02541-0","article-title":"Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sj\u00f6gren\u2019s syndrome by modulating the balance of Treg and Th17 cells","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.coi.2025.102714_bib38","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s10787-023-01189-x","article-title":"Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4+ T cells in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Ma","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.coi.2025.102714_bib39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41423-020-00587-3","article-title":"Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sj\u00f6gren\u2019s syndrome by modulating the function of myeloid-derived suppressor cells","volume":"18","author":"Rui","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.871096","article-title":"Labial gland mesenchymal stem cell derived exosomes-mediated miRNA-125b attenuates experimental Sjogren\u2019s syndrome by targeting PRDM1 and suppressing plasma cells","volume":"13","author":"Xing","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.871096","article-title":"Labial gland mesenchymal stem cell derived exosomes-mediated miRNA-125b attenuates experimental Sjogren\u2019s syndrome by targeting PRDM1 and suppressing plasma cells","volume":"13","author":"Xing","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102714_sbref42","article-title":"Effect of adipose tissue-derived stem cells therapy on clinical response in patients with primary Sjogren\u2019s syndrome","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102714_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sjogren\u2019s syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.coi.2025.102714_sbref44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2023.11.007","article-title":"Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sj\u00f6gren\u2019s syndrome: a randomized clinical trial","volume":"31","author":"M\u00f8ller-Hansen","year":"2024","journal-title":"Ocul Surf"},{"key":"10.1016\/j.coi.2025.102714_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/scrt336","article-title":"Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells","volume":"4","author":"Ribeiro","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.coi.2025.102714_bib46","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/scd.2017.0045","article-title":"Characteristics of Labial gland mesenchymal stem cells of healthy individuals and patients with Sj\u00f6gren\u2019s syndrome: a preliminary study","volume":"26","author":"Wang","year":"2017","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.coi.2025.102714_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.coi.2025.102714_bib48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/bloodadvances.2017006205","article-title":"Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFN\u03b3 priming","volume":"1","author":"Chinnadurai","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2025.102714_bib49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy","volume":"18","author":"von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.coi.2025.102714_bib50","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved mesenchymal stromal cells are susceptible to T-cell mediated apoptosis which is partly rescued by IFN\u03b3 licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.coi.2025.102714_bib51","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1089\/ten.tea.2008.0630","article-title":"Requirement of IFN-\u03b3\u2013mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose\u2013derived stem cells","volume":"15","author":"DelaRosa","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.coi.2025.102714_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coi.2025.102714_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2012.67","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?","volume":"91","author":"Griffin","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.coi.2025.102714_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01626","article-title":"Anti-donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning?","volume":"8","author":"Lohan","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102714_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.coi.2025.102714_bib56","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/bloodadvances.2020001711","article-title":"Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match","volume":"4","author":"Giri","year":"2020","journal-title":"Blood Adv"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:34:08Z","timestamp":1784540048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"alternative-id":["S0952791525001906"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102714","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of stromal cell immunobiology in understanding and managing Sj\u00f6gren\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102714"}}